Alvarez-Herrera, S.; Rosel Vales, M.; Pérez-Sánchez, G.; Becerril-Villanueva, E.; Flores-Medina, Y.; Maldonado-GarcÃa, J.L.; Saracco-Alvarez, R.; Escamilla, R.; Pavón, L.
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia. Pharmaceuticals 2024, 17, 167.
https://doi.org/10.3390/ph17020167
AMA Style
Alvarez-Herrera S, Rosel Vales M, Pérez-Sánchez G, Becerril-Villanueva E, Flores-Medina Y, Maldonado-GarcÃa JL, Saracco-Alvarez R, Escamilla R, Pavón L.
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia. Pharmaceuticals. 2024; 17(2):167.
https://doi.org/10.3390/ph17020167
Chicago/Turabian Style
Alvarez-Herrera, Samantha, Mauricio Rosel Vales, Gilberto Pérez-Sánchez, Enrique Becerril-Villanueva, Yvonne Flores-Medina, José Luis Maldonado-GarcÃa, Ricardo Saracco-Alvarez, Raúl Escamilla, and Lenin Pavón.
2024. "Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia" Pharmaceuticals 17, no. 2: 167.
https://doi.org/10.3390/ph17020167
APA Style
Alvarez-Herrera, S., Rosel Vales, M., Pérez-Sánchez, G., Becerril-Villanueva, E., Flores-Medina, Y., Maldonado-GarcÃa, J. L., Saracco-Alvarez, R., Escamilla, R., & Pavón, L.
(2024). Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia. Pharmaceuticals, 17(2), 167.
https://doi.org/10.3390/ph17020167
